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Abstract
Subjective tinnitus is a chronic heterogeneous condition that is typically managed using intervention approaches based on
sound devices, psychologically informed therapies, or pharmaceutical products. For clinical trials, there are currently no
common standards for assessing or reporting intervention efficacy. This article reports on the first of two steps to establish a
common standard, which identifies what specific tinnitus-related complaints (‘‘outcome domains’’) are critical and important
to assess in all clinical trials to determine whether an intervention has worked. Using purposive sampling, 719 international
health-care users with tinnitus, health-care professionals, clinical researchers, commercial representatives, and funders were
recruited. Eligibility was primarily determined by experience of one of the three interventions of interest. Following
recommended procedures for gaining consensus, three intervention-specific, three-round, Delphi surveys were delivered
online. Each Delphi survey was followed by an in-person consensus meeting. Viewpoints and votes involved all stakeholder
groups, with approximately a 1:1 ratio of health-care users to professionals. ‘‘Tinnitus intrusiveness’’ was voted in for all three
interventions. For sound-based interventions, the minimum set included ‘‘ability to ignore,’’ ‘‘concentration,’’ ‘‘quality of
sleep,’’ and ‘‘sense of control.’’ For psychology-based interventions, the minimum set included ‘‘acceptance of tinnitus,’’
‘‘mood,’’ ‘‘negative thoughts and beliefs,’’ and ‘‘sense of control.’’ For pharmacology-based interventions, ‘‘tinnitus loudness’’
was the only additional core outcome domain. The second step will next identify how those outcome domains should best
be measured. The uptake of these intervention-specific standards in clinical trials will improve research quality, enhance
clinical decision-making, and facilitate meta-analysis in systematic reviews.
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Introduction
Evidence-based clinical practice relies on findings from
high-quality clinical trials to test whether any individual
intervention is beneficial and safe for patients. The selec-
tion and reporting of outcomes in a clinical trial is one of
the most critical factors in any assessment of the effect-
iveness of an intervention (Noble, 2001). Yet, a recent
systematic review (Hall et al., 2016) found wide diversity
in the outcomes assessed and reported in clinical trials of
tinnitus interventions, with no single outcome being
selected across all studies. Most studies failed to clearly
define the tinnitus-related concepts of interest (Hall
et al., 2016).
In a series of recent articles, arguments have built on
earlier calls (such as Landgrebe et al., 2012) for engaging
the international tinnitus community in addressing these
important methodological issues (Hall, 2017; Hall et al.,
2015, 2016; Londero & Hall, 2017). Outcome diversity
could be reduced through recommendations for a min-
imum reporting standard for outcomes to be assessed
and reported in all clinical trials of tinnitus interventions.
International initiatives are now actively promoting min-
imum reporting standards across clinical trials in all
medical specialties. The Core Outcome Measures in
Effectiveness Trials (COMET) initiative and
COnsensus-based Standards for the selection of health
Measurement Instruments initiative are two prominent
examples that promote robust methodologies for
developing minimum standards for clinical trial out-
comes (see Prinsen et al., 2016; Williamson et al.,
2017). The overall program of work advocated by these
initiatives clearly separates the process of specifying what
to measure (outcome domains) from that of how to
measure it (outcome measurement instruments) into
two discrete and sequential steps. This ordering is inten-
tional so as to encourage open-minded choices about
which therapeutic targets are the most important to the
greatest number of stakeholders and to reduce potential
bias toward selecting measurement instruments simply
on the basis of their popularity or accessibility.
This article reports the methods and findings from the
first step in this process which considers only what tinni-
tus-related outcome domains should form the common
standard, not yet how they should be measured.
Specifically, an outcome domain is any distinct element
of tinnitus (i.e., a patient complaint) which could be
assessed to determine whether an intervention has
worked. A minimum reporting standard for tinnitus clin-
ical trials that recommends what the core outcome
domains should be and how they should be measured
would bring distinct advantages. First, it would enable
robust conclusions to be made about the effectiveness of
tinnitus interventions, by enabling meta-analysis (i.e.,
combining the findings from different studies reporting
the effectiveness of the same tinnitus intervention) and by
supporting direct comparisons of findings across differ-
ent therapeutic approaches (Clarke & Williamson, 2016).
Second, it would reduce the risk of outcome reporting
bias. This refers to when researchers select a subset of the
original measured outcomes for publication based on the
findings obtained after study completion (Dwan,
Gamble, Williamson, & Kirkham, 2013) or when
researchers simply fail to report prespecified outcomes
(Smith, Clarke, Williamson, & Gargon, 2015). Finally,
if people with chronic subjective tinnitus were actively
involved in making the decisions about the common set
of outcomes, then a minimum reporting standard would
also bring face validity to outcome selection. This would
ensure that outcomes and subsequent conclusions are
relevant to the end users. Overall, a minimum reporting
standard would reduce wasteful research (Chalmers &
Glaziou, 2009), promoting international collaboration
and knowledge gain. A minimum standard, or ‘‘core
set,’’ is not restrictive; it does not necessarily exclude
other outcomes from being assessed in individual trials;
it is simply a way to reduce diversity and enable a basis
of comparison from one study to another.
For chronic subjective tinnitus, the process of iden-
tifying a core set of outcome domains, to be commonly
assessed when evaluating an intervention, is somewhat
complicated by the fact that there are different interven-
tion approaches (Baguley, McFerran, & Hall, 2013).
Chronic subjective tinnitus is characterized by not
having a readily identifiable single cause, physiological
or otherwise, and no permanent cure through, for exam-
ple, surgery. Therefore, at this point in time, interven-
tions rely on managing the symptoms of tinnitus, either
by reducing the perception of the tinnitus sounds or
minimizing their impact on the individual’s life. Most
existing management options can be split broadly into
two families: sound- and psychology-based approaches
(e.g., Fuller et al., 2017; Tunkel et al., 2014). Sound-
based approaches include electronic devices that increase
audibility associated with any comorbid hearing loss that
exacerbates the tinnitus (e.g., hearing aids, cochlear
implants) or produce therapeutic sounds to mask or dis-
tract from tinnitus (e.g., wearable sound generators,
mobile phone applications, or the radio; Hoare,
Searchfield, El Refaie, & Henry, 2014; Ramakers, van
Zon, Stegeman, & Grolman, 2015). Psychology-based
approaches can include talking-based methods to help
people deal with how tinnitus makes them feel and
behavior change methods to empower them with ways
of managing it (e.g., cognitive behavioral therapy and
mindfulness; Thompson, Hall, Walker, & Hoare, 2017).
In addition, although there are currently no medications
approved specifically for tinnitus, a variety of licensed
drugs have been used off-label to treat the condition
(Elgoyhen & Langguth, 2010). Licensed medication
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is also prescribed to alleviate common complaints asso-
ciated with tinnitus such as depressive symptoms,
anxiety, and sleep difficulties. Therefore, pharmacol-
ogy-based approaches for tinnitus are an established
medical practice. This informed our decision to consider
pharmacology-based interventions as a third family of
tinnitus management options for the purpose of this pro-
ject. Other therapeutic approaches have been evaluated
in research settings such as neuromodulation therapies
(e.g., repetitive transcranial magnetic stimulation, epi-
dural stimulation) and nonprescription food supple-
ments (e.g., Gingko biloba, zinc supplements), but
national standard intervention options offered to those
people with tinnitus seeking professional advice essen-
tially rely upon sound devices, talking therapies, and
drug products at this time. Each of the family of inter-
vention approaches introduced—sound, psychology, and
pharmacology—has a different therapeutic rationale,
and so it should not be assumed that intervention success
should be assessed using the same set of outcome
domains in all cases.
The project objective was therefore to select the out-
come domains for all future early-phase clinical trials of
sound-, psychology-, and pharmacology-based interven-
tions that target the intervention or management of
chronic subjective tinnitus in adults, regardless of the
specific nature of the intervention or mode of adminis-
tration. To achieve this, three separate development stu-
dies were conducted in parallel, one for each family of
interventions. A wide range of stakeholders with expert
knowledge of tinnitus were engaged in this development
process, which was intended to ensure that each min-
imum reporting standard would represent the views
and interests of all end users, to increase the likelihood
that the wider community would agree with the out-
comes selected, and to enhance the prospect of endorse-
ment and implementation of the recommendations.
While the primary objective was to develop a Core
Outcome Domain Set for the design of clinical trials in
chronic subjective tinnitus, these standards should be
considered for use in other research designs, and notably
in systematic reviews.
Methods
An overview of the development process is provided in
Figure 1, and the phases reported in this article are out-
lined in bold. This article reports the three phases of the
project to establish the Core Outcome Domain Set for
sound-, psychology-, and pharmacology-based interven-
tions, respectively. These three phases comprised the
Core Outcome Measures in Tinnitus International
Delphi (COMiT’ID) study. The first phase comprised
three Delphi surveys to prioritize outcome domains for
each family of interventions. These used three rounds of
questions and were delivered online (e-Delphi) to engage
a large number of international stakeholders. The second
phase involved structured face-to-face meetings with a
smaller subset of stakeholders, allowing for in depth con-
versation to reduce the priority list to a core set. The
third and final phase widened input to all consented
stakeholders inviting them to vote on the intervention-
specific recommendations.
This article adheres to the guidelines for the method-
ology (Williamson et al., 2017) and reporting (Kirkham
et al., 2016) of Core Outcome Domain Set development
studies. The study design was approved by the West
Midlands—Solihull Research Ethics Committee and
Health Research Authority (ref: 17/WM/0095, March
2017), and the protocol is published (Fackrell et al.,
2017). Informed consent was given through the online
e-Delphi process, and written consent was given for par-
ticipation at the consensus meeting.
Participants
Five types of stakeholders were targeted to participate in
the prioritization process; health-care users, health-care
practitioners, clinical researchers, commercial represen-
tatives, and funders. Individuals were invited to partici-
pate using a purposive sampling approach, with
recruitment methods and eligibility criteria detailed in
the protocol (Fackrell et al., 2017). All participants
were required to be at least 18 years old and able to
read, understand, and complete surveys in English.
e-Delphi Surveys
The overall e-Delphi project had a minimum target
sample size of 260 participants across the three
e-Delphi surveys, aiming for a 50:50 balance of health-
care users and professionals and aiming for the minimum
targets to be maintained at Round 3. Commercial repre-
sentatives and funders were pooled in the same group, as
per protocol (Fackrell et al., 2017). Participants could
complete one, two, or three e-Delphi surveys, depending
on his or her level of experience and specific knowledge.
To promote retention of participants, each round was
open for a short time, and the time between rounds
was kept to a minimum. Response rates were regularly
monitored, automated reminders were issued from the
survey software, and personalized e-mail reminders
were sent to target individuals who were yet to complete
the round.
A modified e-Delphi technique was used, presenting
participants with a ‘‘long list’’ of candidate outcome
domains each with a plain language concept definition.
As per protocol (Fackrell et al., 2017), three information
sources were used to create the long list: a systematic
review of outcome domains used in clinical trials of
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Figure 1. Schematic overview for the overall project including three parallel e-Delphi surveys, the corresponding face-to-face meetings
to establish the Core Outcome Domain Set recommendations, and stakeholder voting for each intervention-specific strand. The phases
reported in this article are outlined in bold.
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tinnitus interventions (Hall et al., 2016), a narrative syn-
thesis of research evidence for patient-reported com-
plaints of tinnitus (Hall et al., 2018a), and a thematic
analysis of all items in 23 of the most common tinnitus
questionnaires to identify outcome domains assessed
(unpublished). The long list initially comprised 124 out-
come domains that were reduced to 66 through a series
of health-care user-led decisions, removing or combining
domains with overlapping concepts, not specific to tin-
nitus, or associated with measurement of the construct
(Fackrell et al., 2017; Smith et al., 2018).
All three e-Delphi surveys presented the same list of
66 candidate outcome domains over three rounds, but
outcome domains were scored from the perspective of
the intervention in question. All outcome domains were
retained from one round to the next so that participants
were free to change their scores across rounds. In
Round 1, participants were invited to propose additional
outcome domains. Two members of the Study
Management Team reviewed these proposals, and new
items sufficiently distinct from existing candidate out-
comes were added to the list within the most relevant
category, each with a corresponding plain language con-
cept definition, to be scored by all participants in Rounds
2 and 3.
To engage with international stakeholders, the scoring
process for the three e-Delphi surveys was managed
online using DelphiManager software maintained by
the COMET initiative at the University of Liverpool
(see Williamson et al., 2017). At each round, participants
were asked to think about the importance of each of the
66 tinnitus outcome domains and indicate how import-
ant it is to measure when deciding if a sound-, psych-
ology-, or pharmacology-based tinnitus intervention is
working, respectively. Pharmacology-based interven-
tions specifically excluded herbal remedies and dietary
supplements. Participants scored each outcome domain
using the GRADE scale of 1 to 9 (Guyatt et al., 2011).
Scoring used a Likert scale with additional interpretation
categories; 1 to 3 indicated that the domain was not
important, 4 to 6 indicated it was important but not crit-
ical, and 7 to 9 indicated that it was critically important
in deciding whether a tinnitus intervention is effective.
‘‘Unable to score’’ was always an option, and there
were open-text boxes for adding comments. In the sub-
sequent rounds, participants were presented their previ-
ous score and numerical and graphical feedback on the
distribution of scores for each outcome domain. The
purpose of Round 2 was to enable participants to reflect
on their scores in light of the distribution of scores from
their own stakeholder group and to score the outcomes
again. The purpose of Round 3 was to enable partici-
pants to reflect on their scores in light of the distribution
of scores from all stakeholder groups and to score the
outcomes again. Participant data in which less than 40%
of outcome domains had been scored were removed from
the results presented at subsequent rounds as per proto-
col (Fackrell et al., 2017).
During the e-Delphi surveys, the scoring from each
stakeholder group was kept separate to ensure the inter-
ests of all relevant parties were reflected. From Round 3,
a recommendation for inclusion was defined as at least
70% of the participants in all stakeholder groups scoring
7 to 9 and fewer than 15% in any stakeholder group
scoring 1 to 3.
Face-to-Face Meetings
Participants who responded to5 90% of the outcome
domains in Round 3 of the e-Delphi survey were invited
to participate in a meeting. Participants could only
attend one of the three meetings, irrespective of how
many e-Delphi surveys he or she had completed. There
was an expected 50:50 balance of health-care users and
professionals, including non-U.K. participants.
Each meeting lasted for 1 day, and the discussion was
semistructured according to the nominal group technique
(Harvey & Holmes, 2012) using a blend of whole-group
and subgroup discussions, sharing of ideas and voting
techniques. Participants were encouraged to voice their
opinions, with a prerequisite that all were equal and that
every contribution was valid. The meeting was led by an
impartial facilitator, as well as two ‘‘table hosts’’ whose
role it was to keep a focus and to encourage all partici-
pants to contribute to the subgroup discussions and two
‘‘patient buddies’’ to support the health-care users. The
meetings aimed to reduce the list of candidate domains
identified as important during the e-Delphi to just those
to be included in the Core Outcome Domain Sets.
Initially, the meeting was focused on identifying and
voting on outcomes to be set aside, which should not
be included in the final set. Following this, the discus-
sions were focused on whether each of the remaining
outcomes should be included in the Core Outcome
Domain Set. All decisions about the final selections
were voted in a first round with ‘‘agree’’, ‘‘disagree’’,
or ‘‘unsure’’ as response options. Scores were expressed
as percentages using a real-time, anonymized voting
system (CLiKAPAD Ltd, East Sussex, UK).
For the face-to-face meetings, the criterion for con-
sensus was at least 70% agreement on each vote, but
here, all participants were treated equally, and so votes
were not separated by stakeholder group. Votes that did
not reach consensus for either ‘‘agree’’ or ‘‘disagree’’
were reopened for discussion by the facilitator. In the
final votes, ‘‘unsure’’ responses were discouraged, and
only those outcome domains that reached 70% agree
were included in the Core Outcome Domain Set, with
failure to reach a consensus resulting in the outcome
domain being set aside.
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Final Voting
All e-Delphi survey study participants were given an
opportunity to submit an e-mail vote on the final Core
Outcome Domain Set for each intervention category, with
the response options ‘‘agree’’, ‘‘disagree’’, or ‘‘have no
strong opinion and will go along with the majority.’’
Changes From Protocol
Two changes to the protocol (Fackrell et al., 2017) were
made by the Study Management Team after data ana-
lysis of the e-Delphi Round 3. It was originally planned
to discuss all 66þ outcome domains at the face-to-face
meetings. But instead, only those outcome domains
reaching consensus (70% scoring 7–9 in all stakeholder
groups) were discussed at the face-to-face meeting to
allow participants to focus on discriminating between
those outcome domains most likely to form the min-
imum reporting standard. Second, the protocol had
placed no upper limit on the number of outcome
domains within any Core Outcome Domain Set.
However, it was decided to restrict the maximum
number to six to ensure practicality of use in a clinical
trial. These two procedural changes were proposed to the
participants in each face-to-face meeting and received
majority approval. For the sound-, psychology-, and
pharmacology-based meetings, respectively, votes were
as follows: ‘‘agree’’¼ 89%, 79%, 94%; ‘‘disagree’’¼ 5%,
11%, 6%; and ‘‘unsure’’¼ 5%, 11%, 0%.
Results
Participants
Overall, there were 719 participants across the three
development studies. Round 1 was completed by 670
participants, Round 2 by 586 (87.5%) and Round 3 by
533 (79.6%) giving an acceptable retention rate
(Table 1). The e-Delphi surveys were successful in main-
taining their minimum targets at Round 3.
Figure 2 illustrates the geographical distribution, and
Table 2 shows the age distribution of consented partici-
pants in the three e-Delphi surveys. All continents were
Table 1. Flow of Participants Through the Studies Reporting the Recruitment Target That Was Prespecified in the Protocol (Fackrell
et al., 2017), the Number of Participants Who Consented and Subsequently Completed Each Round of the e-Delphi Survey, and the














Health-care user 60–90 199 182 160 142 78.0 10
Health-care practitioner 20–30 79 70 60 57 81.4 5
Clinical researchers 20–30 36 35 35 34 97.1 3
Commercial reps and funders 20–30 24 21 19 19 90.5 1
Psychology-based interventions
Health-care user 40–60 118 114 97 89 78.1 10
Health-care practitioner 20–30 63 61 57 50 82.0 4
Clinical researchers 20–30 39 39 37 36 92.3 5
Commercial reps and fundersa N/A 4 4 4 3 N/A N/A
Pharmacology-based interventions
Health-care user 30–60 67 62 48 41 66.1 6
Health-care practitioner 10–20 51 47 40 37 78.7 5
Clinical researchers 10–20 20 17 14 13 76.5 2
Commercial reps and funders 10–20 19 18 15 12 66.7 3
Total 719b 670 586 533c 79.6 54
Note. The minimum value in the recruitment target range was expected to be maintained through to Round 3. Retention rate was calculated from Round 1
to Round 3.
aNote that this stakeholder group was not purposively sampled for the psychology-based intervention survey, and so 70% agreement among those
participants was not required for consensus decision-making.
bNote some individuals consented to participate in more than one study, and so when those duplicates have been accounted for, the 719 comprises 641
unique individuals.
cFor those participating in more than one study, when duplicates have been accounted for, the 533 comprises 472 unique individuals.
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represented, although there was an expected bias toward
English-speaking countries and Europe. The tinnitus
population was well represented, with about two thirds
of all health-care users aged older than 50 years. There
were 31 journal editors. Health-care practitioners pre-
dominantly identified themselves as audiologists, hearing
therapists, otolaryngologists, and psychologists, with a
small number of neurologists, psychiatrists, general prac-
titioners, and physical therapists.
For each face-to-face meeting, there was a maximum
of 20 places, but not all places were filled despite sending
invitation reminders. Nineteen participants met to dis-
cuss the sound-based Core Outcome Domain Set, 19
met for the psychology-based Core Outcome Domain
Set, and 16 met for the pharmacology-based Core
Outcome Domain Set. The distribution of participants
across stakeholder groups is shown in Table 1. Each
meeting comprised relevant health-care practitioners
Figure 2. World map illustrating the geographical dispersal of all consenting participants across studies. Regional groupings are inspired
by the World Health Organization (WHO) regional classification. To reflect English language-speaking countries, the WHO region of the
Americas was separated into North and South America. Similarly, Australia and New Zealand were considered separately from the
Western Pacific region, as Oceania. Country-specific data indicate only two participants in Africa, and so this was combined with countries
in the WHO Eastern Mediterranean region to create the Middle East and Africa region.
Table 2. Age of All Consented e-Delphi Participants Split by Stakeholder Group.
Stakeholder group 18–29 years 30–49 years 50–69 years 70–89 years Total
Health-care users 22 (6) 98 (26) 218 (57) 46 (12) 384
Health-care practitioners 7 (3) 87 (42) 108 (52) 4 (2) 206
Clinical researchers 7 (9) 43 (52) 31 (38) 1 (1) 82
Commercial reps and funders 1 (2) 24 (51) 21 (45) 1 (2) 47
All stakeholder groups 37 (5) 252 (35) 378 (53) 52 (7) 719
Note. Percentages within each stakeholder group are reported in parentheses.
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from each major clinical specialty. Furthermore, all
meetings had representation from outside the United
Kingdom (sound-based meeting: France, Germany,
Netherlands; psychology-based meeting: Belgium,
France; pharmacology-based meeting: Belgium, Brazil,
France, Germany, Portugal, Spain, Switzerland).
e-Delphi Surveys
Sixty-six outcome domains were presented in Round 1 of
the e-Delphi survey (Supplementary File 1). Overall, 213
feedback comments about potential additional outcome
domains were made during Round 1. From this feed-
back, the Study Management Team added seven new
outcome domains to all three e-Delphi surveys
(Supplementary File 1). From the sound-based survey
feedback, additional outcome domains were ‘‘device
usage’’ and ‘‘frequency of occurrence of tinnitus epi-
sodes.’’ From the psychology-based feedback, they
were ‘‘guilt,’’ ‘‘monitoring,’’ ‘‘self-harm,’’ and ‘‘teeth
clenching’’; and for the pharmacology-based feedback,
they were ‘‘frequency of occurrence of tinnitus episodes’’
and ‘‘pharmacodynamics.’’ Comments also led to revised
wording of the original plain language concept defin-
itions for seven outcome domains, which were changed
for the subsequent rounds of all three e-Delphi surveys
(Supplementary File 1). Of the remaining feedback com-
ments, more than one third of these suggestions dupli-
cated concepts in the original list (38%), while others
considered items that had been excluded at the stage of
preparing the long list because they were multidomain
concepts (12%), described a comorbidity (12%), or were
more associated with how to measure (12%).
Following completion of Round 3, 47 of the 68 can-
didate outcome domains for the sound-based Core
Outcome Domain Set were ruled out because they did
not meet the prespecified consensus definition. For the
psychology-based Core Outcome Domain Set, 46 of the
70 candidate outcome domains were ruled out, and for
the pharmacology-based Core Outcome Domain Set, 51
of the 68 candidate outcome domains were ruled out
(Supplementary File 2). The remaining outcome
domains are reported in Table 3. These were all con-
sidered important and critical according to the consensus
definition for the e-Delphi survey.
Face-to-Face Meetings
Sound-based outcome domains. Twenty-one outcome
domains were taken to the face-to-face meeting with
the goal to restrict the maximum number to six
(Table 3). During the discussion of the outcome
domain ‘‘helplessness (lack of control),’’ participants
asked the facilitator to share the Round 3 scores for
the discarded domain ‘‘sense of control’’ as they felt
the two concepts were somewhat similar but that
‘‘sense of control’’ would be preferable due to its more
positive phrasing and thus fewer negative connotations.
From the e-Delphi sound-based survey, the Round 3
scores (i.e., score 7–9) for ‘‘sense of control’’ had just
missed the consensus definition (health-care
users¼ 84.5%, health-care practitioners¼ 87.7%, clin-
ical researchers¼ 64.7%, and commercial representatives
and funders¼ 94.7%). The proposal for ‘‘sense of con-
trol’’ to replace ‘‘helplessness’’ in the further discussion
was put to vote and agreed by 95% of participants (see
Table 4 and Supplementary File 3). After voting, five
outcome domains met the consensus definition for inclu-
sion in the Core Outcome Domain Set for early-phase
clinical trials of sound-based interventions: ‘‘ability to
ignore,’’ ‘‘concentration,’’ ‘‘sense of control,’’ ‘‘quality
of sleep,’’ and ‘‘tinnitus intrusiveness.’’ Meeting votes
and reasons supporting their inclusion are described in
Table 4. Supplementary File 3 gives reasons for setting
aside the remaining 17 outcome domains.
Psychology-based outcome domains. Twenty-four outcome
domains were taken to the face-to-face meeting
(Table 3). After discussion and voting, five outcomes
were recommended as the Core Outcome Domain Set
for early-phase clinical trials of psychology-based inter-
ventions: ‘‘acceptance of tinnitus,’’ ‘‘mood,’’ ‘‘negative
thoughts/beliefs,’’ ‘‘sense of control,’’ and ‘‘tinnitus
intrusiveness.’’ Meeting votes and reasons supporting
their inclusion are described in Table 5. Supplementary
File 4 gives reasons for setting aside the remaining 19
outcome domains.
Pharmacology-based outcome domains. Seventeen outcome
domains were taken to the face-to-face meeting
(Table 3). Only ‘‘tinnitus intrusiveness’’ and ‘‘tinnitus
loudness’’ were recommended as the final set of core out-
comes for early-phase drug trials. Meeting votes and rea-
sons supporting their inclusion are described in Table 6.
Supplementary File 5 gives reasons for setting aside the
remaining outcome domains.
Final Voting
When the five outcome domains for sound-based inter-
ventions were shared with the original 338 e-Delphi par-
ticipants, 144 responded and 142 voted in favor (98.6%).
When the five outcome domains for psychology-based
interventions were shared with the original 224 e-
Delphi participants, 101 responded and 100 (99.0%)
voted in favor. From the original 157 e-Delphi partici-
pants in the pharmacology-based survey, 64 out of 66
(97.0%) voted in favor of tinnitus loudness and intru-
siveness. Just four participants dissented by voting ‘‘dis-
agree,’’ and these were followed up in an e-mail exchange
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to understand their reason for voting in this way. One
voter highlighted the importance of assessing and report-
ing adverse effects, and one considered the drug-based
standard to be too small. Two dissenting voices raised
concerns that differed fundamentally from the intended
purpose of the project; one argued for research on the
causes of tinnitus, and the other argued for a focus on
‘‘diagnostic imaging.’’ Figure 3 summarizes the
COMiT’ID study recommendations for Core Outcome
Domain Sets for chronic subjective tinnitus in adults.
Discussion
Core outcome domain sets to be included in clinical trials
of interventions for adult chronic subjective tinnitus were
identified and agreed upon, for sound- (five domains),
psychology- (five domains), and pharmacology-based
(two domains) interventions, respectively. Participants
agreed tinnitus intrusiveness was relevant and critical
no matter what tinnitus intervention was being evalu-
ated. This is an important finding because this outcome
could provide a point of comparison across any clinical
trial of a tinnitus intervention. Sense of control provides
another point of comparison, at least being relevant for
sound- and psychology-based approaches.
Although the three Core Outcome Domain Sets all
promote intervention-related benefits, this should not
downgrade the importance of assessing and reporting
intervention-related harms (e.g., Ioannidis et al., 2004).
In particular, discussion around the pharmacology-
based standard explicitly acknowledged the importance
of reported adverse events as a minimum requirement
expected by the regulatory authorities.
The Core Outcome Domain Set are intended to rep-
resent a minimum reporting standard, chosen to be clin-
ically meaningful and with an expectation of change as a
result of intervention. Nevertheless, investigators may
always be free to include additional outcomes that are
important to the participant group or intervention of
interest, as long as the core sets are assessed and reported
as well. For example, in a trial testing cognitive behav-
ioral therapy as an intervention for those with
Table 3. All Outcome Domains That Reached the Prespecified Consensus Definition Based on the e-Delphi Round 3 Voting.
Sound-based interventions Psychology-based interventions Pharmacology-based interventions
Ability to ignore Ability to ignore Ability to ignore
Ability to relax Acceptance of tinnitus Adverse reaction





Coping Depressive symptoms Depressive symptoms
Depressive symptoms Difficulties getting to sleep Difficulties getting to sleep
Difficulties getting to sleep Fear Impact on individual activities
Frequency of occurrence of tinnitus episodes Helplessness (lack of control) Impact on social life
Helplessness (lack of control)a Impact on individual activities Impact on work
Impact on individual activities Impact on relationships Quality of sleep
Impact on social life Impact on social life Tinnitus intrusiveness
Impact on work Impact on work Tinnitus loudness
Listening Irritable Tinnitus unpleasantness
Quality of sleep Mood Treatment satisfaction
Tinnitus awareness Negative thoughts/beliefs
Tinnitus intrusiveness Quality of sleep
Tinnitus unpleasantness Sense of control




Note. These outcomes were agreed to be important and critical for deciding whether or not an intervention for tinnitus is working. Outcome domains
highlighted in bold font are those that were recommended in the final Core Outcome Domain Sets.
aNote that the concept ‘‘helplessness’’ was replaced by ‘‘sense of control’’ during the face-to-face meeting discussion on sound-based interventions, and so
the recommendation is for ‘‘sense of control.’’
Hall et al. 9
sleep-related difficulties, it would be justifiable to select
‘‘quality of sleep’’ as the primary outcome despite it not
being in the core set selected for psychology-based inter-
ventions, as long as the core set were all assessed as sec-
ondary outcomes.
Strengths and Limitations in the Development Process
The COMiT’ID study represents the first time that large
numbers of the international tinnitus community have
made a consensus-based decision about good practice
in clinical trial design and reporting. Not only is this
initiative unique in the field of tinnitus, it is exceptional
in the field of adult hearing health care, because to our
knowledge, no other Core Outcome Domain Set exists in
this area. There was no compelling rationale for con-
straining the therapeutic benefits of the three different
intervention approaches to be identical. The votes at
each round, the discussion at the consensus meeting,
and the final voting rounds were all conducted independ-
ently at each point in the study. A more detailed com-
parative analysis of the e-Delphi voting is reported in a
Table 4. Meeting Votes and Comments in Favor and Against Explaining the Reasons for Recommending the Five Outcome Domains for
Evaluating Sound-Based Interventions.
Outcome domains Vote Comments in favor Comments against
Ability to ignore 89  Linked to, but more relevant than, ‘‘tinnitus annoyance’’
 Considered one of the primary objectives for using a
sound therapy
No strong views expressed
Concentration 74  Relevant to many different aspects of life
 The group recommended that the ‘‘measure of con-
centration’’ should include a question about
conversations.
 Narrowly focussed
 Already encompassed by ‘‘ability to
ignore’’





95  Describes a similar state as ‘‘helplessness’’ but one that
is less extreme
 The group believed this to be highly relevant to sound-
based treatments that many felt can give people direct
‘‘control’’ over their tinnitus
 One participant explained that sound-based therapy
literally allowed him to ‘‘turn his tinnitus off.’’
 One subgroup felt that ‘‘sense of control’’ might cover
‘‘coping’’ as this was more about feelings of managing
tinnitus, which also would encompass impact of activ-
ities, relationships, and social life that have been
removed.
No strong views expressed
Quality of sleep 79  Strong feeling that sound-based therapies (as an inter-
vention category) are directly relevant to addressing
sleep complaints associated with tinnitus.
 Currently, sound therapies play a major role in
improving sleep.
 The group acknowledged this as one of the most
reported complaints associated with tinnitus.
 Argued to be highly important, given the potential to
have an impact on overall well-being and given its
influence on a variety of other domains.
 Some felt that ‘‘quality of sleep’’ was
perhaps secondary to ‘‘intrusiveness’’
and ‘‘ability to ignore.’’
 The group acknowledged that sleep
complaints were not relevant to all
people with tinnitus, and therefore, it
was questioned whether this domain
should be ‘‘core.’’
 Some felt sleep problems were more
relevant to the acute/initial phase of
tinnitus and therefore maybe not
appropriate for the Core Outcome
Domain Set which should be relevant




100  Broad coverage of tinnitus impact (e.g., can cover
aspects of sleep, listening, conversation, etc.)
 Captures the emotional impact of tinnitus where
‘‘tinnitus awareness’’ does not
One participant questioned whether ‘‘tin-
nitus awareness’’ would be more
important, given that it is the ‘‘root’’ of
tinnitus intrusiveness.
Note. Votes represent the % of the 19 participants who agreed that these outcome domains should be included in the Core Outcome Domain Set.
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separate article (Hall et al., 2018b). Ultimately, the min-
imum reporting standards chosen for each intervention
approach comprised a number of unique outcome
domains not selected for the other two intervention
approaches. We feel that this result confirmed our deci-
sion to conduct parallel Delphi surveys, but the process
might equally have identified a common set of outcome
domains across all three intervention approaches. The
result was not biased by the procedure. The final three
sets of recommendations that emerged from the consen-
sus decision-making process comprised outcome
domains individually chosen according to those patients’
needs that are most directly addressed by each interven-
tion approach.
Tinnitus is not necessarily unique because other
health-related conditions are also treated by a range of
intervention approaches. Chronic pain is one good
example as it can be managed using approaches that
include medications, psychology-based approaches,
physical therapy, and complementary therapies. The
IMMPACT group (Initiative on Methods,
Measurement, and Pain Assessment in Clinical Trials)
called to address this challenge by developing a core set
of outcome domains that should be considered in all
clinical trials of interventions for chronic pain, with fur-
ther outcome domains to be added depending on the
nature of the intervention and population to whom the
intervention is targeted (Turk & Dworkin, 2004).
Conceptually speaking, the COMiT’ID study is similar
in its approach, but the benefit is that COMiT’ID iden-
tified from a single study what should be the common
minimum standard for all trials and what should be the
intervention-specific outcome domains. A number of
other recent initiatives have similarly developed min-
imum reporting standards that are specific to a particular
intervention strategy in cases where a broad range of
intervention options exist. For example, the
COMMENT group (Consensus group on Outcome
Table 5. Meeting Votes and Comments in Favor and Against Explaining the Reasons for Recommending the Five Outcome Domains for
Evaluating Psychology-Based Interventions.
Outcome
domains Vote Comments in favor Comments against
Acceptance
of tinnitus
84  Some stated that acceptance is an important
starting point from where the person with tin-
nitus can start to move on.
 Others felt ‘‘acceptance of tinnitus’’ was more
important than ‘‘sense of control.’’
Some felt this was a more ‘‘passive’’ domain that
does not accurately reflect a reduction of the
impact of/ distress caused by tinnitus.
Mood 100  The group made a strong recommendation that
the experience of ‘‘anxiety’’ and ‘‘depressive
symptoms’’ should be added to the concept
definition of ‘‘mood.’’




79 No strong views expressed  Some felt that this is more a process in the
therapy than an outcome measure.
 Some suggested this was more relevant to
some psychological treatments than to others.
Sense of
control
84  The group observed that ‘‘sense of control’’ is
particularly about feeling in control over the
impact of tinnitus, perhaps as a consequence of
mastering more positive coping strategies.
 A construct that covers many aspects relating to
tinnitus
 Considered most important when symptoms are
severe (e.g., sleep difficulties)
 One patient felt that this is an ‘‘active’’ domain
(unlike acceptance) that can represent a strong
motivator for a patient to use a treatment.
 Some felt that applying coping techniques was
more important than developing a sense of
control.
 The definition was considered to be too broad.
 It could be encapsulated by other outcome
domains.
 Some participants disliked the term control, as
this term is not well aligned with psychological




95  The definition should describe in more detail in
which way tinnitus can be intrusive. For this
group, that meant impact on social life, impact on
work, impact on relationships, impact on indi-
vidual activities, difficulties getting to sleep, and
quality of sleep.
No strong views expressed
Note. Votes represent the % of the 19 participants who agreed that these outcome domains should be included in the Core Outcome Domain Set.
Hall et al. 11
Figure 3. Graphic illustrating the COMiT’ID recommendations for Core Outcome Domain Sets for each family of interventions widely
available for chronic subjective tinnitus in adults.
Table 6. Meeting Votes and Comments in Favor and Against, Explaining the Reasons for Recommending the Two Outcome Domains for
Evaluating Pharmacology-Based Interventions.
Outcome
domains Vote Comments in favor Comments against
Tinnitus
intrusiveness
100  The group felt that ‘‘intrusiveness’’ captures aspects of tinnitus
that are more relevant than ‘‘loudness’’ alone.
 ‘‘Tinnitus intrusiveness’’ is related to ‘‘loudness’’ but is distinct
from it. It is a target for developing a tinnitus cure based on
pharmacology.
 Comment indicated that this is a relatively broad construct
that could be sensitive to the impact of tinnitus in a variety of
areas of life (quality of life).
 A few participants believed ‘‘intru-
siveness’’ is a subdomain of loud-
ness (i.e., you cannot have
intrusiveness without loudness).
 The concept of intrusiveness may
be problematic to explain consist-




100  ‘‘Tinnitus loudness’’ is all about the sensation of the sound. It is
the direct target for drug treatments. Fix this and you fix
everything else.
 The group considered this to be a ‘‘semiobjective’’ measure
and therefore reliable and critical to include alongside the
more ‘‘subjective’’ domains.
 The group felt that ‘‘loudness’’ needs to be measured along-
side with intrusiveness as they interrelate but are separate.
Some acknowledged that a change in
loudness may not always reflect a
tangible benefit on the patient’s life.
Note. Votes represent the % of the 16 participants who agreed that these outcome domains should be included in the Core Outcome Domain Set.
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Measures Made in pediatric Enteral Nutrition clinical
Trials) separated recommendations for outcome
domains relevant to clinical trials on preventing acute
diarrhea from those relevant to treating the symptoms
(Karas et al., 2015). Similarly, an international group
interested in vaccination communication identified
three different outcome domains based on whether the
intended purpose of the communication was to inform or
educate, to remind, or to engage the community
(Kaufman et al., 2017). These examples illustrate how
collective stakeholder responses prioritize different out-
come domains for different types of interventions, and
how minimum reporting standards need to be sensitive
to those differences.
The Core Outcome Domain Set has been developed
using robust methodology in accordance with recom-
mendations from the COMET initiative (Kirkham
et al., 2016). Recruitment exceeded its target, with wide
representation across stakeholder groups and satisfac-
tory retention from Round 1 to Round 3 of the
e-Delphi survey. Retention rate met the 80% criterion
for what is generally deemed satisfactory in the develop-
ment of a Core Outcome Domain Set (Williamson et al.,
2017). The purposive involvement of health-care users
with tinnitus and the requirement for each selected out-
come domain to have reached 70% consensus within all
stakeholder groups avoids any risk that the outcome
domain recommendations are biased in favor of clin-
icians and researchers. Moreover, the final voting step
ensured that a wider group of international stakeholders
were given the opportunity to express an opinion about
the recommended common standards. In this respect, the
Core Outcome Domain Set represents a major advance-
ment on the earlier consensus statement for tinnitus
intervention outcome measurement made by just 29
attendees at Tinnitus Research Initiative meeting in
Regensburg (Langguth et al., 2007). We note that all of
these original attendees were invited, and many did par-
ticipate in the current development process. We therefore
strongly believe the present recommendations are repre-
sentative of the priorities and views shared by the major-
ity of the tinnitus community.
As far as possible, it is important for Core Outcome
Domain Sets to incorporate an international perspective
(Williamson et al., 2017). Despite purposive sampling,
there were still relatively low numbers of participants
from Africa, Asia, and South America. There are a
number of possible explanations for these limiting
geographical biases. First, they reflect known biases in
tinnitus clinical trial activity (Hall et al., 2016). Second,
the study materials were produced in English and as a
consequence would have reduced participation from
countries where English is not widely spoken. With
respect to the face-to-face meetings, participation from
distant countries was made difficult by the choice of
U.K. locations (Sheffield and London), and although
European Union funding was available to support par-
ticipants from across Europe, it still limited participation
from elsewhere. To counteract this, the more inter-
national community of e-Delphi participants were
invited to evaluate and endorse the Core Outcome
Domain Set recommendations in a final vote once
reports of the meetings were shared. This step achieved
a lower response rate (45%) in final voting but an
overwhelming support in favor (98%). Comments were
actioned, where possible. For example, our recommen-
dations highlight the importance of assessing and report-
ing adverse effects despite it not reaching the threshold
for consensus, and we invite investigators to consider
assessing other relevant domains in addition to the min-
imum standard.
Implication of the Standards for Complex
Interventions and Novel Interventions
With the exception of tinnitus intrusiveness, the differing
composition of the three Core Outcome Domain Sets
demonstrates how selection of outcome domains
cannot be generalized from one family of interventions
to another. For example, while ‘‘sense of control’’
was judged to be critical and important for evaluating
sound- and psychology-based interventions, for pharma-
cology-based interventions, it failed even to reach the
prespecified consensus criteria in the e-Delphi Round 3
voting. Faced with complex interventions (such as those
combining sound and psychological components of ther-
apy), or novel intervention strategies (such as neuromo-
dulation), a good starting point would be to consider
whether any components of the three existing standards
are applicable. Certainly, ‘‘tinnitus intrusiveness’’ is a
good candidate because it has been shown to be relevant
to at least three different classes of intervention.
Investigators may wish to consider additional outcome
domains that are directly applicable to the intervention
of interest. In such cases, there may be value in measur-
ing outcome domains that are unrepresented in the cur-
rent standard. For example, for early-phase trials
evaluating neuromodulation-based interventions, it
may be appropriate to measure neural activity to dem-
onstrate intervention-related change at the neurophysio-
logical level.
Future Research Directions
Tinnitus can affect people in many different ways, but if
the lived experience of tinnitus and the major interven-
tion strategies are equivalent across cultures, then the
Core Outcome Domain Set recommendations should
be generalizable across countries, irrespective of whether
citizens from that country participated in the
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development process. However, there is a lack of pub-
lished information describing the lived experience of tin-
nitus in different countries because most of the published
literature is limited to the United Kingdom, the United
States, Germany, and Sweden (Hall et al., 2018a). Our
study indicates that such cross-cultural issues warrant
further investigation as a matter of priority.
The next step for the COMiT initiative is to identify
‘‘how’’ the outcomes in each Core Outcome Domain Set
should be measured by making evidence-based decisions
about which instrument best measures each outcome
domain. This will involve three further pieces of work:
first to define more explicitly the concepts and constructs
underpinning each of the selected outcome domains,
second to search for all possible available instruments,
and third to identify those that have acceptable construct
validity and other clinimetric properties (De Vet, Terwee,
Mokkink, & Knol, 2011). When it comes to selecting
measurement instruments, the logical consequence of
the three different Core Outcome Domain Sets is that a
single instrument will not meet the minimum common
standard across sound-, psychology-, and pharmacol-
ogy-based interventions, unless it is for tinnitus intrusive-
ness alone. We acknowledge that this position will
challenge the generally accepted dogma that a single
measurement instrument can ‘‘do the job equally well’’
in all tinnitus trials. Until there can be evidence-based
recommendations about choice of measurement instru-
ments, investigators would be advised in the interim to at
least select instruments that purport to measure each
outcome domain either as a subscale of a multidomain
questionnaire instrument or a single-item numeric rating
scale. Once there is an understanding about how the out-
come domains should be measured, the next step is for
investigators to implement these standardized sets so
that there will be a common point of comparison for
efficacy results across different studies evaluating the
same tinnitus intervention. This will improve transpar-
ency and the ability to compare and combine future stu-
dies with greater ease. Once evidence-based
recommendations are available to inform decisions
about how to best measure the selected outcome
domains, we aspire to conduct an observational cohort
study at 7 years following publication of the recommen-
dations. This study will evaluate uptake of the core out-
comes in clinical trials, other research designs, and in
systematic reviews to review the state of the field, and
if necessary to understand challenges and barriers to
uptake.
Conclusions
Meta-analysis in a systematic review is possible only
when outcome measures are adequately homogenous
(Clarke & Williamson, 2016). It is therefore strongly
advocated that all clinical trials, other research designs,
and systematic reviews use these Core Outcome Domain
Sets. Nevertheless, it is important to appreciate that
while these minimum reporting standards should
always be measured in every clinical trial (at least
before and after the intervention), investigators should
not necessarily feel compelled to specify them as the pri-
mary end points, and they are free to add other outcomes
as they wish relevant to the specific aims and target
population of their research. The recommendations are
intended to provide a framework for greater compatibil-
ity across clinical trials, not to stifle individual prefer-
ences. We wish to avoid potential misunderstandings of
the purpose of the Core Outcome Domain Set, which
may inadvertently limit uptake and implementation.
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